ArticleSleep medicine2025
Idiopathic hypersomnia symptoms over Time: Longitudinal follow up from the Hypersomnia Foundation registry.
Article in Sleep medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Narcolepsy and Idiopathic Hypersomnia Real-World Treatment Patterns and Changes in Alerting Agent Use After Low-Sodium Oxybate Initiation: A Retrospective Claims Analysis.Neurology and therapy · 2026Article
- Clinical and polysomnographic changes in idiopathic hypersomnia ten years after the diagnosis.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
introductionLimited data are available regarding the long-term course of idiopathic hypersomnia. We analyzed longitudinal data from the Hypersomnia Foundation Registry at CoRDS to evaluate changes in symptoms and medication usage over time.
methodsRegistry participants reporting a diagnosis of idiopathic hypersomnia were included if they completed the registry questionnaire at least twice, with at least six months before first and last questionnaire. Responses were analyzed using paired t-test for continuous variables and McNemar test for categorical variables, comparing first and last responses.
resultsData from three hundred twenty-three participants were included, with a mean age 35.0 ± 12.2 and 86.5 % women. Average time between first and last response was 2.4 ± 1.4 years. Symptoms remained largely stable over the 2 ½ year period, with persistent difficulty awakening (in 78.7 % at baseline and 73.0 % at follow up), daytime sleepiness (62.7 % and 61.8 %), trouble waking up and functioning with normal alertness (56.4 % and 56.4 %), requiring multiple alarms (53.4 % and 55.3 %), brain fog (46.3 % and 48.4 %), and memory problems (42.7 % and 43.4 %). Average nightly sleep duration on workdays and non-workdays and average nap duration were all stable over time. Participants made an average of 0.8 ( ± 1.1) medication changes, with most (55.4 %) participants remaining on the same medications. Comorbid mood disorders were relatively common, with a modest increase in anxiety diagnoses.
conclusionsSymptoms of idiopathic hypersomnia remained relatively stable over an average of 2.4 years of follow up. Despite persistent symptoms being experienced by the majority of participants, medication changes were infrequent.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.